Emea] Head of Portfolio Strategy

**Company Description** Santen is a specialized life sciences company with a proud 130-year heritage focused exclusively on ophthalmology. As a Japan-originated, global company with our footprint in over 60 countries, we are dedicated to delivering innovative treatments and digital solutions for eye health and addressing vision-related social issues for people around the world.**

**PURPOSE OF ROLE**

The role will develop and implement strategic plans to optimize the current and future Santen EMEA product portfolio. This includes the development and evolution of the portfolio strategy (aligned with Santen global strategy), identification of Life Cycle Management opportunities for key in-market products, prioritization of disease areas and technology platforms for future growth, partnering with Business Development to identify, assess and introduce new assets to strengthen the pipeline, and leading the early commercial development of new products prior to their assignment to marketing.
**Job Description** In-Market Portfolio Maximization**- ** Analyzing the current Santen portfolio** to develop and implement portfolio strategies aligned with the company's business goals and market trends in the EMEA region with a mid-long-term view to maximize revenue growth and market share, while optimizing profits. Doing so requires close cross-functional collaboration, primarily with the Marketing department as any plan/strategy needs to be dovetailed with the Therapeutic Area Plans developed by the Marketing Directors.
- ** Financial Analysis**: Monitor financial performance of the portfolio, analyze key metrics such as revenue, profitability, and return on investment, and make recommendations for resource allocation and investment decisions. There is also a need to develop and manage a budget including identifying opportunities for savings and efficiencies.
- ** Product Lifecycle Management**: Oversee the entire lifecycle of products in the portfolio, from development and launch to maturity and phase-out, ensuring optimal resource allocation and portfolio optimization.
- ** Portfolio optimization** including portfolio rationalization and divestment of non-priority assets to focus resources for new products addressing high unmet needs with greater potential.

**Future Portfolio Development**- ** Strategic Planning**: Collaborate with cross-functional teams to develop long-term strategic plans that inform and direct portfolio diversification, expansion into new market segments, and strategic partnerships or acquisitions.
- ** Market Analysis**: Conduct comprehensive market analyses to identify priority market segments where the strategic fit with Santen and the unmet need are high, assess competition, and make data-driven decisions about portfolio priorities.
- ** Market intelligence & Trends**: Stay on top of industry trends, market dynamics, competitors’ activities and emerging technologies to identify growth opportunities and threats.
- ** Innovation and Pipeline Development**: Drive innovation by evaluating new product opportunities, supporting R&D initiatives, and managing the pipeline to ensure a robust portfolio of products. To do so, build deep customer, patient and disease insights**by conducting primary and secondary research taking opportunities to learn at congresses and by working closely with the EMEA market research and medical affairs teams, to identify potential new opportunities.
- ** Risk Management**: Identify and mitigate risks related to portfolio decisions, such as regulatory challenges, market shifts, or competitive threats.
- ** Develop business cases and support due-diligence**by developing robust forecasts, scenario analysis and go-to-market models based on solid data from strong market and customer understanding. This requires strong collaboration with marketing, country organizations, business development and finance.

**New Products Commercial Development**- ** Developing robust market understanding**for early new products (earlier than 24-36 from launch) e.g. patient journey, stakeholder mapping, etc.
- ** Early integrated product strategy**:work closely with a cross-functional team including marketing (if the therapy area expertise exists), access, medical and regulatory to develop an integrated product strategy including positioning, evidence generation, pricing strategies, and go-to-market plans.
- ** Implement asset and market shaping strategies**required at this early stage to secure the fulfilment of the strategic imperatives of the product strategy. This includes risk management.
- ** Lead or co-lead product commercialization plans**with launch program management and the relevant functions like development, regulatory, manufacturing, and supply chain.
- ** Stakeholder Engagement**: Engage with internal stakeholders (e.g., senior management, R&D teams, marketing teams, medical affairs, market access, etc.) and external stakeholders (e.g., regulatory authorities, key opinion leaders,